Home LiteratureArticle Details
PMID: 19281271 Published · ppublish English Journal Article Review

Ubiquitin in NF-kappaB signaling.

Chemical reviews ·Vol. 109 ·No. 4 ·2009-04-00 ·Pages 1549-60

Chiu YH, Zhao M, Chen ZJ

Abstract

暂无摘要

MeSH Terms
DNA Damage Gene Expression Regulation I-kappa B Kinase/metabolism NF-kappa B/metabolism Proteasome Endopeptidase Complex/metabolism Protein Kinases/metabolism Signal Transduction Tumor Necrosis Factor Receptor-Associated Peptides and Proteins/metabolism Ubiquitin/metabolism
Chemicals
NF-kappa B Tumor Necrosis Factor Receptor-Associated Peptides and Proteins Ubiquitin Protein Kinases I-kappa B Kinase Proteasome Endopeptidase Complex
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Chiu Yu-Hsin
Department of Molecular Biology and Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9148, USA.
Zhao Meng
Chen Zhijian J
References (143)
143 references, click to expand
  1. Role of the TAB2-related protein TAB3 in IL-1 and TNF signaling.
    EMBO J. 2003 Dec 1;22(23):6277-88 PMID: 14633987
  2. Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb.
    Nature. 1998 Jan 29;391(6666):493-6 PMID: 9461217
  3. Signal processing by its coil zipper domain activates IKK gamma.
    Proc Natl Acad Sci U S A. 2008 Jan 29;105(4):1279-84 PMID: 18216269
  4. The novel functions of ubiquitination in signaling.
    Curr Opin Cell Biol. 2004 Apr;16(2):119-26 PMID: 15196553
  5. Cotranslational biogenesis of NF-kappaB p50 by the 26S proteasome.
    Cell. 1998 Mar 20;92(6):819-28 PMID: 9529257
  6. A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-kappaB activation.
    EMBO J. 2008 Jan 23;27(2):373-83 PMID: 18079694
  7. TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway.
    Mol Cell. 2000 Apr;5(4):649-58 PMID: 10882101
  8. Ubiquitination of RIP is required for tumor necrosis factor alpha-induced NF-kappaB activation.
    J Biol Chem. 2006 May 12;281(19):13636-13643 PMID: 16543241
  9. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses.
    Nat Immunol. 2004 Oct;5(10):1052-60 PMID: 15334086
  10. Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli.
    Science. 2006 Feb 24;311(5764):1141-6 PMID: 16497931
  11. Structural basis for recognition of diubiquitins by NEMO.
    Mol Cell. 2009 Mar 13;33(5):602-15 PMID: 19185524
  12. Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK.
    Nat Immunol. 2008 Dec;9(12):1371-8 PMID: 18997794
  13. Ubiquitin: a Nobel protein.
    Cell. 2004 Dec 17;119(6):741-5 PMID: 15607971
  14. ABIN-2 is required for optimal activation of Erk MAP kinase in innate immune responses.
    Nat Immunol. 2006 Jun;7(6):606-15 PMID: 16633345
  15. Key function for the Ubc13 E2 ubiquitin-conjugating enzyme in immune receptor signaling.
    Nat Immunol. 2006 Sep;7(9):962-70 PMID: 16862162
  16. In vitro assembly and recognition of Lys-63 polyubiquitin chains.
    J Biol Chem. 2001 Jul 27;276(30):27936-43 PMID: 11369780
  17. TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains.
    Mol Cell. 2004 Aug 27;15(4):535-48 PMID: 15327770
  18. PIASy mediates NEMO sumoylation and NF-kappaB activation in response to genotoxic stress.
    Nat Cell Biol. 2006 Sep;8(9):986-93 PMID: 16906147
  19. The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense.
    Sci STKE. 2003 Feb 25;2003(171):re3 PMID: 12606705
  20. Noncanonical MMS2-encoded ubiquitin-conjugating enzyme functions in assembly of novel polyubiquitin chains for DNA repair.
    Cell. 1999 Mar 5;96(5):645-53 PMID: 10089880
  21. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity.
    Nature. 2007 Apr 19;446(7138):916-920 PMID: 17392790
  22. Two TNF receptors.
    Immunol Today. 1992 May;13(5):151-3 PMID: 1322675
  23. Productive RUPture: activation of transcription factors by proteasomal processing.
    Biochim Biophys Acta. 2004 Nov 29;1695(1-3):209-13 PMID: 15571816
  24. Cell biology. Kinasing and clipping down the NF-kappa B trail.
    Science. 2005 Apr 1;308(5718):65-6 PMID: 15802594
  25. Ubiquitin signalling in the NF-kappaB pathway.
    Nat Cell Biol. 2005 Aug;7(8):758-65 PMID: 16056267
  26. Mechanisms of ubiquitin-mediated, limited processing of the NF-kappaB1 precursor protein p105.
    Biochimie. 2001 Mar-Apr;83(3-4):341-9 PMID: 11295495
  27. The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO.
    Curr Biol. 2004 Dec 29;14(24):2217-27 PMID: 15620648
  28. Molecular mechanisms involved in the regulation of cytokine production by muramyl dipeptide.
    Biochem J. 2007 Jun 1;404(2):179-90 PMID: 17348859
  29. TRAF6 is a T cell-intrinsic negative regulator required for the maintenance of immune homeostasis.
    Nat Med. 2006 Sep;12(9):1088-92 PMID: 16921377
  30. The CARMA1 signalosome links the signalling machinery of adaptive and innate immunity in lymphocytes.
    Nat Rev Immunol. 2006 Nov;6(11):799-812 PMID: 17063183
  31. IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis.
    Cell. 2007 Nov 16;131(4):669-81 PMID: 18022362
  32. Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology.
    Biochem J. 2004 Sep 1;382(Pt 2):393-409 PMID: 15214841
  33. Regulation of IkappaB kinase-related kinases and antiviral responses by tumor suppressor CYLD.
    J Biol Chem. 2008 Jul 4;283(27):18621-6 PMID: 18467330
  34. Two pathways to NF-kappaB.
    Mol Cell. 2002 Oct;10(4):693-5 PMID: 12419209
  35. The human T-cell leukemia virus type 1 Tax oncoprotein requires the ubiquitin-conjugating enzyme Ubc13 for NF-kappaB activation.
    J Virol. 2007 Dec;81(24):13735-42 PMID: 17942533
  36. Proteolysis of NF-kappaB1 p105 is essential for T cell antigen receptor-induced proliferation.
    Nat Immunol. 2009 Jan;10(1):38-47 PMID: 19060899
  37. Dual effects of IkappaB kinase beta-mediated phosphorylation on p105 Fate: SCF(beta-TrCP)-dependent degradation and SCF(beta-TrCP)-independent processing.
    Mol Cell Biol. 2004 Jan;24(1):475-86 PMID: 14673179
  38. Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis.
    EMBO J. 2001 Mar 15;20(6):1271-80 PMID: 11250893
  39. The kinase TAK1 integrates antigen and cytokine receptor signaling for T cell development, survival and function.
    Nat Immunol. 2006 Aug;7(8):851-8 PMID: 16799562
  40. Lys63-linked polyubiquitination of IRAK-1 is required for interleukin-1 receptor- and toll-like receptor-mediated NF-kappaB activation.
    Mol Cell Biol. 2008 May;28(10):3538-47 PMID: 18347055
  41. A novel type of deubiquitinating enzyme.
    J Biol Chem. 2003 Jun 20;278(25):23180-6 PMID: 12682062
  42. A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein.
    Science. 1989 Mar 24;243(4898):1576-83 PMID: 2538923
  43. A pervasive role of ubiquitin conjugation in activation and termination of IkappaB kinase pathways.
    EMBO Rep. 2005 Apr;6(4):321-6 PMID: 15809659
  44. TNF-R1 signaling: a beautiful pathway.
    Science. 2002 May 31;296(5573):1634-5 PMID: 12040173
  45. Identification of the familial cylindromatosis tumour-suppressor gene.
    Nat Genet. 2000 Jun;25(2):160-5 PMID: 10835629
  46. Retroviral oncoprotein Tax deregulates NF-kappaB by activating Tak1 and mediating the physical association of Tak1-IKK.
    EMBO Rep. 2007 May;8(5):510-5 PMID: 17363973
  47. Critical roles of TRAF2 and TRAF5 in tumor necrosis factor-induced NF-kappa B activation and protection from cell death.
    J Biol Chem. 2001 Sep 28;276(39):36530-4 PMID: 11479302
  48. The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination.
    Nature. 2003 Aug 14;424(6950):801-5 PMID: 12917691
  49. NEMO recognition of ubiquitinated Bcl10 is required for T cell receptor-mediated NF-kappaB activation.
    Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3023-8 PMID: 18287044
  50. RBCK1 negatively regulates tumor necrosis factor- and interleukin-1-triggered NF-kappaB activation by targeting TAB2/3 for degradation.
    J Biol Chem. 2007 Jun 8;282(23):16776-82 PMID: 17449468
  51. A ubiquitin mutant with specific defects in DNA repair and multiubiquitination.
    Mol Cell Biol. 1995 Mar;15(3):1265-73 PMID: 7862120
  52. Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected].
    Nat Cell Biol. 2006 Apr;8(4):398-406 PMID: 16547522
  53. Ubiquitin chain editing revealed by polyubiquitin linkage-specific antibodies.
    Cell. 2008 Aug 22;134(4):668-78 PMID: 18724939
  54. Ubiquitin-conjugating enzyme Ubc13 is a critical component of TNF receptor-associated factor (TRAF)-mediated inflammatory responses.
    Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6371-6 PMID: 17404240
  55. Persistent activation of NF-kappaB by the tax transforming protein of HTLV-1: hijacking cellular IkappaB kinases.
    Oncogene. 1999 Nov 22;18(49):6948-58 PMID: 10602469
  56. The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes.
    Mol Cell. 2004 May 7;14(3):289-301 PMID: 15125833
  57. Bcl10 activates the NF-kappaB pathway through ubiquitination of NEMO.
    Nature. 2004 Jan 8;427(6970):167-71 PMID: 14695475
  58. Intracellular NOD-like receptors in host defense and disease.
    Immunity. 2007 Oct;27(4):549-59 PMID: 17967410
  59. Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation.
    Cell. 1998 Jun 26;93(7):1231-40 PMID: 9657155
  60. Back to the future with ubiquitin.
    Cell. 2004 Jan 23;116(2):181-90 PMID: 14744430
  61. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling.
    Nat Genet. 2001 Mar;27(3):277-85 PMID: 11242109
  62. Tax ubiquitylation and sumoylation control critical cytoplasmic and nuclear steps of NF-kappaB activation.
    Blood. 2006 May 15;107(10):4021-9 PMID: 16424386
  63. Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway.
    Science. 2001 Aug 24;293(5534):1495-9 PMID: 11520989
  64. Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO.
    Mol Cell. 2006 Apr 21;22(2):245-57 PMID: 16603398
  65. Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice.
    Immunity. 1997 Nov;7(5):715-25 PMID: 9390694
  66. TAB2 is essential for prevention of apoptosis in fetal liver but not for interleukin-1 signaling.
    Mol Cell Biol. 2003 Feb;23(4):1231-8 PMID: 12556483
  67. Site-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of I kappa B kinase activation.
    J Biol Chem. 2007 Feb 9;282(6):4102-12 PMID: 17135271
  68. TRAF2 is essential for JNK but not NF-kappaB activation and regulates lymphocyte proliferation and survival.
    Immunity. 1997 Nov;7(5):703-13 PMID: 9390693
  69. NF-kappaB1/p105 regulates lipopolysaccharide-stimulated MAP kinase signaling by governing the stability and function of the Tpl2 kinase.
    Mol Cell. 2003 Mar;11(3):685-94 PMID: 12667451
  70. TNF-alpha induces two distinct caspase-8 activation pathways.
    Cell. 2008 May 16;133(4):693-703 PMID: 18485876
  71. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling.
    Nature. 2004 Aug 5;430(7000):694-9 PMID: 15258597
  72. Molecular basis for the unique deubiquitinating activity of the NF-kappaB inhibitor A20.
    J Mol Biol. 2008 Feb 15;376(2):526-40 PMID: 18164316
  73. Quantitative analysis of in vitro ubiquitinated cyclin B1 reveals complex chain topology.
    Nat Cell Biol. 2006 Jul;8(7):700-10 PMID: 16799550
  74. Transcriptional activation of the tumor necrosis factor alpha-inducible zinc finger protein, A20, is mediated by kappa B elements.
    J Biol Chem. 1992 Sep 5;267(25):17971-6 PMID: 1381359
  75. DUBA: a deubiquitinase that regulates type I interferon production.
    Science. 2007 Dec 7;318(5856):1628-32 PMID: 17991829
  76. CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members.
    Nature. 2003 Aug 14;424(6950):793-6 PMID: 12917689
  77. Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif.
    EMBO J. 2006 Jul 26;25(14):3257-63 PMID: 16858409
  78. Regulation of DNA repair by ubiquitylation.
    Nat Rev Mol Cell Biol. 2006 May;7(5):323-34 PMID: 16633336
  79. Mechanism and function of deubiquitinating enzymes.
    Biochim Biophys Acta. 2004 Nov 29;1695(1-3):189-207 PMID: 15571815
  80. Ubiquitination and translocation of TRAF2 is required for activation of JNK but not of p38 or NF-kappaB.
    EMBO J. 2004 Jan 28;23(2):322-32 PMID: 14713952
  81. Expression of the NF-kappaB inhibitor ABIN-3 in response to TNF and toll-like receptor 4 stimulation is itself regulated by NF-kappaB.
    J Cell Mol Med. 2008 Jan-Feb;12(1):316-29 PMID: 18081698
  82. Cutting edge: K63-linked polyubiquitination of NEMO modulates TLR signaling and inflammation in vivo.
    J Immunol. 2008 Jun 1;180(11):7107-11 PMID: 18490708
  83. Cutting Edge: Pivotal function of Ubc13 in thymocyte TCR signaling.
    J Immunol. 2006 Dec 1;177(11):7520-4 PMID: 17114420
  84. NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100.
    Mol Cell. 2001 Feb;7(2):401-9 PMID: 11239468
  85. TAK1 is a ubiquitin-dependent kinase of MKK and IKK.
    Nature. 2001 Jul 19;412(6844):346-51 PMID: 11460167
  86. A genomic and functional inventory of deubiquitinating enzymes.
    Cell. 2005 Dec 2;123(5):773-86 PMID: 16325574
  87. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes.
    Cell. 2003 Jul 25;114(2):181-90 PMID: 12887920
  88. Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity.
    Cell. 1996 Mar 22;84(6):853-62 PMID: 8601309
  89. Ubiquitination of RIP1 regulates an NF-kappaB-independent cell-death switch in TNF signaling.
    Curr Biol. 2007 Mar 6;17(5):418-24 PMID: 17306544
  90. Proteasome-mediated protein processing by bidirectional degradation initiated from an internal site.
    Nat Struct Mol Biol. 2006 Aug;13(8):691-7 PMID: 16845392
  91. TAK1 is indispensable for development of T cells and prevention of colitis by the generation of regulatory T cells.
    Int Immunol. 2006 Oct;18(10):1405-11 PMID: 16940043
  92. Ubiquitin: roles in protein modification and breakdown.
    Cell. 1983 Aug;34(1):11-2 PMID: 6309404
  93. Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress.
    Cell. 2003 Nov 26;115(5):565-76 PMID: 14651848
  94. The E3 ligase Itch negatively regulates inflammatory signaling pathways by controlling the function of the ubiquitin-editing enzyme A20.
    Nat Immunol. 2008 Mar;9(3):254-62 PMID: 18246070
  95. Essential role of TAK1 in thymocyte development and activation.
    Proc Natl Acad Sci U S A. 2006 Aug 1;103(31):11677-82 PMID: 16857737
  96. Interleukin-1 (IL-1) induces the Lys63-linked polyubiquitination of IL-1 receptor-associated kinase 1 to facilitate NEMO binding and the activation of IkappaBalpha kinase.
    Mol Cell Biol. 2008 Mar;28(5):1783-91 PMID: 18180283
  97. Regulation of transcription by ubiquitination without proteolysis: Cdc34/SCF(Met30)-mediated inactivation of the transcription factor Met4.
    Cell. 2000 Aug 4;102(3):303-14 PMID: 10975521
  98. Malt1 ubiquitination triggers NF-kappaB signaling upon T-cell activation.
    EMBO J. 2007 Nov 14;26(22):4634-45 PMID: 17948050
  99. Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling.
    Nat Immunol. 2008 Dec;9(12):1364-70 PMID: 18997792
  100. Regulation of the NF-kappaB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation.
    J Biol Chem. 2004 Jun 18;279(25):26243-50 PMID: 15084608
  101. Ubiquitin enters the new millennium.
    Mol Cell. 2001 Sep;8(3):499-504 PMID: 11583613
  102. Ubiquitin binding mediates the NF-kappaB inhibitory potential of ABIN proteins.
    Oncogene. 2008 Jun 12;27(26):3739-45 PMID: 18212736
  103. TRAF6 ubiquitin ligase is essential for RANKL signaling and osteoclast differentiation.
    Biochem Biophys Res Commun. 2007 Aug 10;359(4):1044-9 PMID: 17572386
  104. The DNA damage response: ten years after.
    Mol Cell. 2007 Dec 14;28(5):739-45 PMID: 18082599
  105. TPL-2 kinase regulates the proteolysis of the NF-kappaB-inhibitory protein NF-kappaB1 p105.
    Nature. 1999 Jan 28;397(6717):363-8 PMID: 9950430
  106. Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling.
    Cell. 2006 May 19;125(4):665-77 PMID: 16713561
  107. Tumor necrosis factor (TNF)-induced germinal center kinase-related (GCKR) and stress-activated protein kinase (SAPK) activation depends upon the E2/E3 complex Ubc13-Uev1A/TNF receptor-associated factor 2 (TRAF2).
    J Biol Chem. 2003 Apr 25;278(17):15429-34 PMID: 12591926
  108. cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination.
    Mol Cell. 2008 Jun 20;30(6):689-700 PMID: 18570872
  109. Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125.
    Proc Natl Acad Sci U S A. 2007 May 1;104(18):7500-5 PMID: 17460044
  110. Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice.
    Science. 2000 Sep 29;289(5488):2350-4 PMID: 11009421
  111. Control of meiotic and mitotic progression by the F box protein beta-Trcp1 in vivo.
    Dev Cell. 2003 Jun;4(6):799-812 PMID: 12791266
  112. p105 and p98 precursor proteins play an active role in NF-kappa B-mediated signal transduction.
    Genes Dev. 1993 Apr;7(4):705-18 PMID: 8458581
  113. Inflammatory cardiac valvulitis in TAX1BP1-deficient mice through selective NF-kappaB activation.
    EMBO J. 2008 Feb 20;27(4):629-41 PMID: 18239685
  114. NF-kappaB activation: Nondegradative ubiquitination implicates NEMO.
    Trends Immunol. 2006 Sep;27(9):395-7 PMID: 16857427
  115. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B.
    Cell. 1994 Sep 9;78(5):773-85 PMID: 8087845
  116. Involvement of linear polyubiquitylation of NEMO in NF-kappaB activation.
    Nat Cell Biol. 2009 Feb;11(2):123-32 PMID: 19136968
  117. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB.
    Nature. 2003 Aug 14;424(6950):797-801 PMID: 12917690
  118. TAK1-binding protein 1, TAB1, mediates osmotic stress-induced TAK1 activation but is dispensable for TAK1-mediated cytokine signaling.
    J Biol Chem. 2008 Nov 28;283(48):33080-6 PMID: 18829460
  119. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway.
    Genes Dev. 1995 Jul 1;9(13):1586-97 PMID: 7628694
  120. Exclusive ubiquitination and sumoylation on overlapping lysine residues mediate NF-kappaB activation by the human T-cell leukemia virus tax oncoprotein.
    Mol Cell Biol. 2005 Dec;25(23):10391-406 PMID: 16287853
  121. Structural mechanism of RNA recognition by the RIG-I-like receptors.
    Immunity. 2008 Aug 15;29(2):178-81 PMID: 18701081
  122. Ubiquitin-binding domains.
    Biochem J. 2006 Nov 1;399(3):361-72 PMID: 17034365
  123. Tumor suppressor CYLD regulates JNK-induced cell death in Drosophila.
    Dev Cell. 2007 Sep;13(3):446-54 PMID: 17765686
  124. The structure of the CYLD USP domain explains its specificity for Lys63-linked polyubiquitin and reveals a B box module.
    Mol Cell. 2008 Feb 29;29(4):451-64 PMID: 18313383
  125. The ubiquitin-editing enzyme A20 restricts nucleotide-binding oligomerization domain containing 2-triggered signals.
    Immunity. 2008 Mar;28(3):381-90 PMID: 18342009
  126. Structure of the A20 OTU domain and mechanistic insights into deubiquitination.
    Biochem J. 2008 Jan 1;409(1):77-85 PMID: 17961127
  127. Zinc-finger protein A20, a regulator of inflammation and cell survival, has de-ubiquitinating activity.
    Biochem J. 2004 Mar 15;378(Pt 3):727-34 PMID: 14748687
  128. NOD2 pathway activation by MDP or Mycobacterium tuberculosis infection involves the stable polyubiquitination of Rip2.
    J Biol Chem. 2007 Dec 14;282(50):36223-9 PMID: 17947236
  129. Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer.
    Nat Rev Cancer. 2008 Jun;8(6):438-49 PMID: 18500245
  130. HTLV-1 Tax-mediated TAK1 activation involves TAB2 adapter protein.
    Biochem Biophys Res Commun. 2008 Jan 4;365(1):189-94 PMID: 17986383
  131. The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response.
    EMBO Rep. 2008 Sep;9(9):930-6 PMID: 18636086
  132. Discovery of HTLV-1, the first human retrovirus, its unique regulatory mechanisms, and insights into pathogenesis.
    Oncogene. 2005 Sep 5;24(39):5931-7 PMID: 16155600
  133. A ubiquitin ligase complex essential for the NF-kappaB, Wnt/Wingless, and Hedgehog signaling pathways.
    Genes Dev. 1999 Mar 1;13(5):505-10 PMID: 10072378
  134. Two distinct ubiquitin-dependent mechanisms are involved in NF-kappaB p105 proteolysis.
    Biochem Biophys Res Commun. 2006 Jun 23;345(1):7-13 PMID: 16678126
  135. TRAF6 autoubiquitination-independent activation of the NFkappaB and MAPK pathways in response to IL-1 and RANKL.
    PLoS One. 2008;3(12):e4064 PMID: 19112497
  136. All TRAFs are not created equal: common and distinct molecular mechanisms of TRAF-mediated signal transduction.
    J Cell Sci. 2002 Feb 15;115(Pt 4):679-88 PMID: 11865024
  137. Deubiquitylation and regulation of the immune response.
    Nat Rev Immunol. 2008 Jul;8(7):501-11 PMID: 18535581
  138. Antiviral innate immunity pathways.
    Cell Res. 2006 Feb;16(2):141-7 PMID: 16474426
  139. Shared principles in NF-kappaB signaling.
    Cell. 2008 Feb 8;132(3):344-62 PMID: 18267068
  140. Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain.
    Cell. 2000 Oct 13;103(2):351-61 PMID: 11057907
  141. The kinase activity of Rip1 is not required for tumor necrosis factor-alpha-induced IkappaB kinase or p38 MAP kinase activation or for the ubiquitination of Rip1 by Traf2.
    J Biol Chem. 2004 Aug 6;279(32):33185-91 PMID: 15175328
  142. PIDD mediates NF-kappaB activation in response to DNA damage.
    Cell. 2005 Dec 16;123(6):1079-92 PMID: 16360037
  143. ABIN-2 forms a ternary complex with TPL-2 and NF-kappa B1 p105 and is essential for TPL-2 protein stability.
    Mol Cell Biol. 2004 Jun;24(12):5235-48 PMID: 15169888
Article Info
Journal
Chemical reviews
Abbr.
Chem Rev
ISSN
1520-6890
DOI
10.1021/cr800554j
Published
2009-04-00
Pages
1549-60
Language
English
Region
United States
NLM ID
2985134R
PMCID
PMC2735462
Subset
IM
Grants
NIAID NIH HHS · R01 AI060919 · United States
NIAID NIH HHS · R01 AI060919-05 · United States
NIGMS NIH HHS · R01 GM063692 · United States
NIGMS NIH HHS · R01 GM063692-08 · United States
External Links
PubMed source DOI: 10.1021/cr800554j PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2